250 related articles for article (PubMed ID: 33374819)
1. Novel Advances in Modifying BMPR2 Signaling in PAH.
Dannewitz Prosseda S; Ali MK; Spiekerkoetter E
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374819
[TBL] [Abstract][Full Text] [Related]
2. FHIT, a Novel Modifier Gene in Pulmonary Arterial Hypertension.
Dannewitz Prosseda S; Tian X; Kuramoto K; Boehm M; Sudheendra D; Miyagawa K; Zhang F; Solow-Cordero D; Saldivar JC; Austin ED; Loyd JE; Wheeler L; Andruska A; Donato M; Wang L; Huebner K; Metzger RJ; Khatri P; Spiekerkoetter E
Am J Respir Crit Care Med; 2019 Jan; 199(1):83-98. PubMed ID: 30107138
[TBL] [Abstract][Full Text] [Related]
3. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension.
Awad KS; Wang S; Dougherty EJ; Keshavarz A; Demirkale CY; Yu ZX; Miller L; Elinoff JM; Danner RL
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791441
[TBL] [Abstract][Full Text] [Related]
4. Impaired Interleukin-15 Signaling via
Hilton LR; Rätsep MT; VandenBroek MM; Jafri S; Laverty KJ; Mitchell M; Theilmann AL; Smart JA; Hawke LG; Moore SD; Renaud SJ; Soares MJ; Morrell NW; Ormiston ML
Hypertension; 2022 Nov; 79(11):2493-2504. PubMed ID: 36043416
[TBL] [Abstract][Full Text] [Related]
5. PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension.
Hennigs JK; Cao A; Li CG; Shi M; Mienert J; Miyagawa K; Körbelin J; Marciano DP; Chen PI; Roughley M; Elliott MV; Harper RL; Bill MA; Chappell J; Moonen JR; Diebold I; Wang L; Snyder MP; Rabinovitch M
Circ Res; 2021 Feb; 128(3):401-418. PubMed ID: 33322916
[TBL] [Abstract][Full Text] [Related]
6. PTPN1 Deficiency Modulates BMPR2 Signaling and Induces Endothelial Dysfunction in Pulmonary Arterial Hypertension.
Ali MK; Tian X; Zhao L; Schimmel K; Rhodes CJ; Wilkins MR; Nicolls MR; Spiekerkoetter EF
Cells; 2023 Jan; 12(2):. PubMed ID: 36672250
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2.
Novoyatleva T; Rai N; Kojonazarov B; Veeroju S; Ben-Batalla I; Caruso P; Shihan M; Presser N; Götz E; Lepper C; Herpel S; Manaud G; Perros F; Gall H; Ghofrani HA; Weissmann N; Grimminger F; Wharton J; Wilkins M; Upton PD; Loges S; Morrell NW; Seeger W; Schermuly RT
Commun Biol; 2021 Aug; 4(1):1002. PubMed ID: 34429509
[TBL] [Abstract][Full Text] [Related]
8. [Heritable pulmonary arterial hypertension].
Eichstaedt CA; Shaukat M; Grünig E
Inn Med (Heidelb); 2024 Jun; 65(6):560-565. PubMed ID: 38771375
[TBL] [Abstract][Full Text] [Related]
9. Schistosomiasis-associated pulmonary hypertension unveils disrupted murine gut-lung microbiome and reduced endoprotective Caveolin-1/BMPR2 expression.
Marinho Y; Villarreal ES; Aboagye SY; Williams DL; Sun J; Silva CLM; Lutz SE; Oliveira SD
Front Immunol; 2023; 14():1254762. PubMed ID: 37908354
[TBL] [Abstract][Full Text] [Related]
10.
Hemnes AR; Fessel JP; Chen X; Zhu S; Fortune NL; Jetter C; Freeman M; Newman JH; West JD; Talati MH
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L429-L441. PubMed ID: 31850803
[TBL] [Abstract][Full Text] [Related]
11. An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.
Ainscough AJ; Smith TJ; Haensel M; Rhodes CJ; Fellows A; Whitwell HJ; Vasilaki E; Gray K; Freeman A; Howard LS; Wharton J; Dunmore B; Upton PD; Wilkins MR; Edel JB; Wojciak-Stothard B
Commun Biol; 2022 Nov; 5(1):1192. PubMed ID: 36344664
[TBL] [Abstract][Full Text] [Related]
12. Sex-biased TGFβ signalling in pulmonary arterial hypertension.
Wits M; Becher C; de Man F; Sanchez-Duffhues G; Goumans MJ
Cardiovasc Res; 2023 Oct; 119(13):2262-2277. PubMed ID: 37595264
[TBL] [Abstract][Full Text] [Related]
13. Imaging Features in
Zhao Q; Zhang R; Shi J; Xie H; Zhang L; Li F; Jiang R; Wu W; Luo C; Qiu H; Li H; He J; Yuan P; Liu J; Gong S; Wang L
Radiology; 2023 Jun; 307(5):e222488. PubMed ID: 37191488
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis.
Crosby A; Soon E; Jones FM; Southwood MR; Haghighat L; Toshner MR; Raine T; Horan I; Yang P; Moore S; Ferrer E; Wright P; Ormiston ML; White RJ; Haight DA; Dunne DW; Morrell NW
Am J Respir Crit Care Med; 2015 Dec; 192(11):1355-65. PubMed ID: 26308618
[TBL] [Abstract][Full Text] [Related]
15. Reduced FOXF1 links unrepaired DNA damage to pulmonary arterial hypertension.
Isobe S; Nair RV; Kang HY; Wang L; Moonen JR; Shinohara T; Cao A; Taylor S; Otsuki S; Marciano DP; Harper RL; Adil MS; Zhang C; Lago-Docampo M; Körbelin J; Engreitz JM; Snyder MP; Rabinovitch M
Nat Commun; 2023 Nov; 14(1):7578. PubMed ID: 37989727
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and Clinical Profiles of Pulmonary Arterial Hypertension Patients with GDF2 and BMPR2 Variants.
Wang MT; Weng KP; Chang SK; Huang WC; Chen LW
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473983
[TBL] [Abstract][Full Text] [Related]
17. Genetics and mediators in pulmonary arterial hypertension.
Austin ED; Loyd JE
Clin Chest Med; 2007 Mar; 28(1):43-57, vii-viii. PubMed ID: 17338927
[TBL] [Abstract][Full Text] [Related]
18. Functional changes in pulmonary arterial endothelial cells associated with BMPR2 mutations.
Wang H; Ji R; Meng J; Cui Q; Zou W; Li L; Wang G; Sun L; Li Z; Huo L; Fan Y; Penny DJ
PLoS One; 2014; 9(9):e106703. PubMed ID: 25187962
[TBL] [Abstract][Full Text] [Related]
19. Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Welch CL; Aldred MA; Balachandar S; Dooijes D; Eichstaedt CA; Gräf S; Houweling AC; Machado RD; Pandya D; Prapa M; Shaukat M; Southgate L; Tenorio-Castano J; ; Chung WK;
Genet Med; 2023 Nov; 25(11):100925. PubMed ID: 37422716
[TBL] [Abstract][Full Text] [Related]
20. Heritable Pulmonary Arterial Hypertension Diagnosed during the Postpartum Period: A Case Report and Literature Review.
Çolak A; Kumral Z; Özpelit E; Akdeniz B
Turk Kardiyol Dern Ars; 2023 Oct; 51(7):498-501. PubMed ID: 37861253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
